The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 02, 2026
Snapshot (as of Oct 02, 2026): Labcorp Holdings Inc. (LH) pays a $2.88 annual dividend ($0.72 quarterly), yielding 0.94% at $305.30/share. Next ex-dividend date 2026-08-28. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 0.94%
Annual Dividend: $2.88 per share
Payout Ratio: 23.9%
Ex-Dividend Date: 2026-08-28
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 10
Labcorp Holdings Inc. dividend investors are working with a company that provides diagnostic laboratory services to physicians, hospitals, pharmaceutical companies, and patients. LH currently pays $2.88 per share annually, distributed quarterly, with the next ex-dividend date on August 28, 2026. The current yield sits at 0.88%. With a beta of 0.851, LH stock carries below-market price volatility, which appeals to income investors who prioritize steadiness over high current payouts.
Labcorp Holdings Inc. pays out 23.9% of earnings as dividends, a payout ratio classified as conservative (below 40%). That low payout leaves substantial earnings headroom, and the company's role in delivering diagnostic laboratory services to healthcare facilities and pharmaceutical firms points to demand that does not disappear in economic downturns. The most data-supported pressure on Labcorp Holdings Inc. dividend safety is the flat dividend per share from 2023 through 2025, which shows growth has stalled despite the low payout.
Labcorp Holdings Inc. dividend history shows a CAGR of 6.3% per year from 1992 to 2025. Per-share payments grew from $0.38 to $2.88 over that period (2026 is a partial year and excluded from this calculation). The largest annual increase in the available window was 657.9% in 2023, which reflects a dramatic step-up from a period of suppressed payments rather than a sustained acceleration in growth.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +15.8% | $1.86 (2022) | $2.88 (2025) |
| 5-Year | +33.2% | $0.69 (1993) | $2.88 (2025) |
LH stock fits dividend investors who value a low-risk payout structure over a high current income stream. The yield is low (below 2%), currently at 0.88%, which is only modestly above the 5-year average of 0.83%, so there is no meaningful yield expansion on offer. Four consecutive years of dividend increases and a 23.9% payout ratio show the company is not stretching to maintain the dividend. The trade-off is clear: income is modest, growth has been flat since 2023, and the diagnostic laboratory services business supports the payout without pressure, but does not drive rapid dividend expansion.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-28 | $0.7200 |
| 2026-05-29 | $0.7200 |
| 2026-02-27 | $0.7200 |
| 2025-11-26 | $0.7200 |
| 2025-08-28 | $0.7200 |
| 2025-05-29 | $0.7200 |
| 2025-02-27 | $0.7200 |
| 2024-11-26 | $0.7200 |
| 2024-08-29 | $0.7200 |
| 2024-05-24 | $0.7200 |
| Year | Total Dividends |
|---|---|
| 2026 | $2.1600 |
| 2025 | $2.8800 |
| 2024 | $2.8800 |
| 2023 | $2.6772 |
| 2022 | $1.8558 |
Project income from LH with the LH dividend calculator or track your full portfolio with the dividend tracker.